Her doctoral research focused on stem cell responses to microbial infection and the potential therapeutic implications of such responses. Her subsequent postdoctoral research investigated the relationship between the TRPA1 ion channel and inflammation in temporomandibular disorders (TMD), with the aim of identifying new therapeutic targets for managing TMD-related pain and inflammation. Prior to her Ph.D., Harriet worked as a scientist within the in vitro diagnostics industry, where her responsibilities included large-scale data analysis and quality assurance/quality control (QA/QC) of diagnostic machinery.

Harriet's IP work encompasses a broad range of life sciences technologies, including therapeutic antibodies, small molecule therapeutics, lipid nanoparticles, vaccines, and medical devices. She is experienced in conducting prior art searches, file history reviews, freedom-to-operate (FTO) analyses, and identifying expert witnesses. She also has experience drafting patent claim charts and advising on infringement and validity analyses, as well as claim construction arguments. In addition, Harriet has extensive experience in large-scale technical document review and IP portfolio due diligence. She has completed secondments with the IP litigation team in the A&O Shearman Boston office and with the A&O Shearman Belfast Data Science Team.

Beyond life sciences, Harriet has an interest in the innovative use of legal technology. She has authored several white papers for the firm's Future Disputes Group and co-authored a paper on the legal implications of explaining artificial intelligence.